TMVR

What Is TMVR?

Transcatheter mitral valve replacement, abbreviated TMVR, is a minimally invasive procedure that replaces a diseased mitral valve using a catheter delivered device rather than traditional open heart surgery. The mitral valve sits between the left atrium and left ventricle, and when it becomes severely diseased, whether through narrowing, leakage, or a combination of both, replacing it can restore more normal blood flow through the heart.¹

TMVR developed later than its counterpart for the aortic valve, largely because the mitral valve presents unique anatomical challenges. Its shape is complex and saddle like rather than simply circular, it works alongside a network of supporting cords and muscles known as the subvalvular apparatus, and it sits in close proximity to the aortic valve and the outflow path leading out of the heart, all of which complicate device design and delivery.²

Today, TMVR is used in several distinct clinical situations. It can replace a previously implanted surgical valve or repair ring that has failed over time, or it can address significant calcification of the native mitral annulus. Dedicated devices designed specifically for native mitral valve disease are also available for select patients whose anatomy is not suited to less invasive repair options.¹

Transcatheter mitral valve replacement has provided better clinical outcomes, decreased hospital stay, and reduced mortality rates for appropriately selected patients.
National Center for Biotechnology Information

How Does TMVR Work?

The replacement valve used in TMVR is compressed to fit within a delivery catheter, allowing it to be guided into the heart through a blood vessel rather than requiring an incision into the chest. Most procedures use a transseptal approach, in which the catheter is guided into the right atrium and then crosses through the wall separating the two upper heart chambers to reach the left atrium and, ultimately, the mitral valve.³

Once positioned within the diseased valve, previously failed surgical valve, or calcified annulus, the new valve is expanded into place, most often using a balloon expandable design. The new valve immediately begins regulating blood flow between the left atrium and left ventricle, taking over the function of the original, diseased valve.¹

Because the mitral valve sits so close to the aortic valve and the left ventricular outflow tract, physicians rely heavily on advanced imaging, particularly transesophageal echocardiography and detailed pre procedural CT scanning, to plan exact device sizing and positioning and to anticipate any risk of obstructing blood flow out of the heart.⁴

Who Needs TMVR?

TMVR is generally reserved for patients with significant mitral valve disease who face elevated risk from traditional open heart surgery, whether due to age, other medical conditions, or a history of prior cardiac surgery that makes repeat open heart intervention more complex.⁵

Patients with a previously implanted surgical bioprosthetic valve or annuloplasty ring that has failed over time, developing either narrowing or leakage, represent one of the most well established candidate groups, since the existing surgical hardware provides a stable anatomical landing zone for the new transcatheter valve.¹

Patients with significant mitral annular calcification, in which calcium deposits stiffen and distort the native valve structure, and select patients with native mitral valve disease not well suited to less invasive repair techniques, may also be considered candidates, though careful anatomical screening excludes a substantial proportion of patients evaluated for this specific indication.⁶

The Procedure

TMVR is typically performed under general anesthesia in a specialized hybrid operating room or catheterization laboratory equipped with advanced imaging capability. The procedure generally takes three to four hours to complete, reflecting the detailed imaging guidance required throughout each step.³

After the delivery catheter reaches the mitral valve position through the transseptal approach, the replacement valve is carefully positioned and deployed under continuous echocardiographic and fluoroscopic guidance, allowing the physician to confirm accurate placement before fully releasing the device.³

Following deployment, the care team assesses the new valve’s function and checks specifically for any evidence of obstruction to blood flow leaving the heart, a particular concern with this procedure given the anatomical relationship between the mitral valve and the outflow tract.⁴

Risks and Complications

Paravalvular leak, in which blood flows around rather than through the new valve, is among the more common complications following TMVR, particularly in patients with complex or irregular annular anatomy that makes a complete seal more difficult to achieve.⁶

Left ventricular outflow tract obstruction represents one of the most serious and TMVR specific risks, occurring when the new valve or the displaced native valve tissue narrows the pathway blood normally takes out of the heart. This risk is carefully assessed during pre procedural imaging, though it cannot always be entirely eliminated even with careful planning.⁶

Hemolysis, a condition in which red blood cells are damaged as they pass through or around the new valve, can occur in some patients, particularly when a degree of paravalvular leak is present. Patients undergoing TMVR for severe mitral annular calcification face meaningfully higher procedural risk overall compared with those undergoing valve in valve or valve in ring procedures, reflecting the more complex and distorted anatomy typically present in calcification related cases.⁷

Life After TMVR

Most patients experience meaningful improvement in symptoms such as shortness of breath and fatigue within weeks of the procedure, reflecting more normal blood flow through the newly functioning mitral valve.⁵

Antithrombotic medication is generally prescribed following the procedure to reduce the risk of clot formation on the new valve, and regular follow up with echocardiography allows the care team to confirm the valve continues functioning well and to monitor for any signs of paravalvular leak or other late complications.¹

Recovery time following TMVR is generally shorter than that associated with traditional open heart mitral valve surgery, allowing many patients, particularly those who were previously considered too high risk for surgery, to return home and resume daily activities more quickly than would otherwise have been possible.⁵

Outcomes and Effectiveness

Outcomes following TMVR vary considerably depending on the specific clinical situation being treated. Valve in valve and valve in ring procedures, performed in patients with a previously failed surgical valve or ring, have generally shown more favorable outcomes than procedures performed for native valve disease complicated by significant annular calcification.⁷

Long term survival data illustrate this difference clearly, with five year survival rates considerably higher for valve in valve and valve in ring patients compared with those undergoing TMVR specifically for severe mitral annular calcification, a group that continues to face meaningfully higher procedural risk and mortality.⁷

Dedicated devices designed specifically for native mitral valve disease continue to evolve, with early results showing meaningful clinical improvement in the large majority of patients who survive the procedure and reach follow up evaluation, even as researchers continue refining patient selection criteria and device technology to improve outcomes further.⁶

Why Visual Communication Matters for TMVR

The mitral valve’s complex, saddle shaped anatomy and its close relationship to the aortic valve and outflow tract make TMVR one of the most difficult structural heart procedures to explain using words alone. Patients and even some clinical teams benefit enormously from clear visuals showing exactly how a catheter delivered valve is positioned within this intricate anatomical space.²

Device manufacturers, structural heart programs, and medical education organizations rely on precise illustration and animation to explain the anatomical challenges specific to TMVR and how each clinical scenario, from valve in valve to native valve disease, differs in approach and risk.

• Illustrating the complex, saddle shaped anatomy of the mitral valve and its supporting structures
• Animating transseptal catheter delivery and expansion of a replacement valve within the mitral position
• Explaining the distinct clinical scenarios addressed by TMVR, including valve in valve, valve in ring, and valve in calcification procedures
• Visualizing the risk of left ventricular outflow tract obstruction and how imaging helps assess it beforehand
• Supporting patient education on candidacy and expected recovery
• Creating training materials for structural heart teams on procedural planning and imaging

How Biotic Artlab Supports TMVR Communication

We collaborate with structural heart device manufacturers, cardiac surgery programs, and healthcare organizations to create precise, engaging visuals that make this technically demanding procedure understandable for patients, clinicians, and industry audiences.

• Custom 3D animations of mitral valve anatomy and transcatheter replacement mechanics
• Detailed illustrations comparing valve in valve, valve in ring, and native valve TMVR approaches
• Patient education materials explaining candidacy, procedure, and recovery
• Clinical training content on pre procedural imaging and outflow tract risk assessment
• Regulatory and investor facing visuals explaining device mechanism of action
• Conference presentations and marketing materials for structural heart audiences

Frequently Asked Questions

Is TMVR the same procedure as TAVR?

No. Both are transcatheter valve replacement procedures, but TAVR treats the aortic valve while TMVR treats the mitral valve, which has more complex anatomy and sits in closer proximity to other important cardiac structures.²

Why is TMVR considered more challenging than TAVR?

The mitral valve has a complex, saddle shaped structure supported by cords and muscles, and it sits close to the aortic valve and the pathway blood takes out of the heart, all of which make device design, delivery, and positioning considerably more difficult than for the aortic valve.²

What is a valve in valve TMVR procedure?

Valve in valve TMVR involves placing a new transcatheter valve inside a previously implanted surgical valve that has failed over time, using the existing surgical valve as a stable anatomical landing zone for the new device.¹

What is the biggest risk specific to TMVR?

Left ventricular outflow tract obstruction is one of the most serious risks specific to TMVR, occurring when the new valve or displaced native tissue narrows the pathway blood takes leaving the heart. Careful pre procedural imaging helps assess and reduce this risk.⁶

Why do outcomes differ so much between TMVR patient groups?

Patients undergoing TMVR for a failed surgical valve or ring generally have more favorable, predictable anatomy than patients with severe native mitral annular calcification, which tends to be more distorted and complex, contributing to meaningfully different outcomes between these groups.⁷

How long does recovery from TMVR take?

Recovery is generally faster than traditional open heart mitral valve surgery, with many patients experiencing symptom improvement within weeks, though the exact recovery timeline depends on the specific clinical scenario and overall health of the patient.⁵

Have a Project in Mind? Contact Us.

If you are developing training materials, patient education content, or marketing visuals related to TMVR or structural heart interventions, our team can help bring the science to life with precision and clarity. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valve or Dedicated Devices, Current Evidence and Future Prospects.
2. National Center for Biotechnology Information. Transcatheter Mitral Valve Replacement, An Alternate Treatment Methodology for Patients at High Surgical Risk.
3. National Center for Biotechnology Information. Transesophageal Echocardiography in Transcatheter Mitral Valve Replacement.
4. National Center for Biotechnology Information. Computed Tomography Planning for Transcatheter Mitral Valve Replacement.
5. National Center for Biotechnology Information. Transcatheter Mitral Valve Replacement in High Surgical Risk Patients, A Single Center Experience and Outcome.
6. National Center for Biotechnology Information. Advances in Transcatheter Mitral Valve Replacement in Patients With Mitral Annular Calcification.
7. National Center for Biotechnology Information. Outcomes After Transcatheter Mitral Valve Replacement in Valve in Valve, Valve in Ring, and Mitral Annular Calcification.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.